D. Sviridov

发表

Lipid metabolism in patients infected with Nef-deficient HIV-1 strain.

H. Low, Lesley Cheng, Maria-Silvana Di Yacovo, 2016, Atherosclerosis.

A Mouse Model of Harlequin Ichthyosis Delineates a Key Role for Abca12 in Lipid Homeostasis

P. Meikle, D. Sviridov, M. Bahlo, 2008, PLoS genetics.

Pentameric CRP attenuates inflammatory effects of mmLDL by inhibiting mmLDL--monocyte interactions.

D. Sviridov, A. Murphy, K. Peter, 2012, Atherosclerosis.

Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome.

G. Watts, D. Sviridov, P. Nestel, 2008, The Journal of clinical endocrinology and metabolism.

Cholesterol efflux from macrophages is influenced differentially by plasmas from overweight insulin-sensitive and -resistant subjects

D. Sviridov, P. Nestel, N. Straznicky, 2012, International Journal of Obesity.

High‐density lipoprotein inhibits human M1 macrophage polarization through redistribution of caveolin‐1

D. Sviridov, A. Murphy, Yi Fu, 2016, British journal of pharmacology.

Stimulation of Liver X Receptor Has Potent Anti-HIV Effects in a Humanized Mouse Model of HIV Infection

M. Bukrinsky, D. Sviridov, L. Dubrovsky, 2015, The Journal of Pharmacology and Experimental Therapeutics.

Liver X receptor agonist inhibits HIV-1 replication and prevents HIV-induced reduction of plasma HDL in humanized mouse model of HIV infection.

F. Kashanchi, M. Bukrinsky, D. Sviridov, 2012, Biochemical and biophysical research communications.

Human immunodeficiency virus infection and macrophage cholesterol metabolism

M. Bukrinsky, D. Sviridov, 2006, Journal of leukocyte biology.

Activated leukocyte cell adhesion molecule is a component of the endothelial junction involved in transendothelial monocyte migration

D. Sviridov, S. Ofori-Acquah, J. King, 2006, FEBS letters.

Skeletal Muscle Insulin Resistance Associated with Cholesterol-Induced Activation of Macrophages Is Prevented by High Density Lipoprotein

P. Meikle, D. Sviridov, B. Kingwell, 2013, PloS one.

Isolated cells in suspension for biological research--Part III. Structure and functional properties of enterocytes and adipocytes.

D. Sviridov, V. Repin, H. Remke, 1988, Experimental pathology.

HDL in Health and Disease: Effects of Exercise and HIV Infection on HDL Metabolism

M. Bukrinsky, D. Sviridov, B. Kingwell, 2007 .

Lipids , Lipoproteins , Cholesteryl Ester Transfer Protein , and Lecithin : Cholesterol Acyltransferase

D. Sviridov, B. Kingwell, P. Nestel, 2004 .

Physical Fitness and Reverse Cholesterol Transport

D. Sviridov, B. Kingwell, P. Nestel, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Intracellular cholesterol trafficking.

D. Sviridov, 1999, Histology and histopathology.

Genetic factors affecting HDL levels, structure, metabolism and function

D. Sviridov, P. Nestel, 2007, Current opinion in lipidology.

Reconstituted HDL: a therapy for atherosclerosis and beyond

D. Sviridov, A. Murphy, J. Chin-Dusting, 2009 .

Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.

D. Sviridov, A. Murphy, B. Kingwell, 2009, Journal of the American College of Cardiology.

High-Density Lipoprotein Reconstituted High-Density Lipoprotein Increases Plasma High-Density Lipoprotein Anti-Inflammatory Properties and Cholesterol Efflux Capacity in Patients With Type 2 Diabetes

D. Sviridov, A. Murphy, B. Kingwell, 2022 .

Effect of weight reduction on the distribution of apolipoprotein A-I in high-density lipoprotein subfractions in obese non-insulin-dependent diabetic subjects.

M. Noakes, P. Clifton, D. Sviridov, 2000, Metabolism: clinical and experimental.

ABCA1 expression in humans is associated with physical activity and alcohol consumption.

D. Sviridov, B. Kingwell, S. Duffy, 2008, Atherosclerosis.

Single session exercise stimulates formation of preβ1-HDL in leg muscle Published, JLR Papers in Press, December 1, 2002. DOI 10.1194/jlr.M200436-JLR200

D. Sviridov, A. Dart, B. Kingwell, 2003, Journal of Lipid Research.

Interaction Between HIV-1 Nef and Calnexin: From Modeling to Small Molecule Inhibitors Reversing HIV-Induced Lipid Accumulation

M. Bukrinsky, D. Sviridov, A. Üren, 2016, Arteriosclerosis, Thrombosis and Vascular Biology.

Atherosclerosis in subjects newly diagnosed with human immunodeficiency virus infection

A. Orekhov, M. Bukrinsky, D. Sviridov, 2018, Bioscience reports.

Low-Density Lipoprotein Receptor and Apolipoprotein A-I and B Expression in Human Enterocytes

D. Sviridov, H. Brewer, J. Hoeg, 2003, Digestion.

Analysis of ABCA1 and Cholesterol Efflux in HIV-Infected Cells.

M. Bukrinsky, D. Sviridov, A. Popratiloff, 2016, Methods in molecular biology.

HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA 1-dependent cholesterol effl ux

M. Bukrinsky, D. Sviridov, K. Gaus, 2012 .

Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents.

D. Sviridov, A. Remaley, D. Osei-Hwedieh, 2011, Pharmacology & therapeutics.

Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin.

G. Watts, D. Sviridov, P. Nestel, 2008, Atherosclerosis.

Interaction of pathogens with host cholesterol metabolism

M. Bukrinsky, D. Sviridov, 2014, Current opinion in lipidology.

A gel-based method for purification of apolipoprotein A-I from small volumes of plasma

D. Sviridov, S. McCormick, Brie Sorrenson, 2010, Journal of Lipid Research.

Expression of Caveolin-1 Enhances Cholesterol Efflux in Hepatic Cells*

D. Sviridov, R. Parton, Z. Krozowski, 2004, Journal of Biological Chemistry.

Isolation of Lipid Rafts from Cultured Mammalian Cells and Their Lipidomics Analysis.

H. Low, P. Meikle, D. Sviridov, 2020, Bio-protocol.

Cholesterol transport between red blood cells and lipoproteins contributes to cholesterol metabolism in blood

H. Low, P. Meikle, D. Sviridov, 2020, Journal of Lipid Research.

HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment.

D. Sviridov, A. Dart, H. Rose, 2006, Metabolism: clinical and experimental.

Effect of dexamethasone on the expression of binding sites for high-density lipoproteins in cultured rat hepatocytes (Independence of the hormone effect on the intracellular cholesterol pool)

E. V. Zaitseva, D. Sviridov, A. Bocharov, 2006, Bulletin of Experimental Biology and Medicine.

Oxidized cholesteryl esters and inflammation.

D. Sviridov, Soo-Ho Choi, Yury I. Miller, 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.

Altered properties of high density lipoprotein subfractions in obese subjects.

D. Sviridov, P. Nestel, N. Fidge, 1997, Journal of lipid research.

Effect of temperature and Ca++ on interaction between high density liproproteins and epithelial cells of the human small intestine

D. Sviridov, V. Repin, I. Safonova, 1989, Bulletin of Experimental Biology and Medicine.

Identification of a Sequence of Apolipoprotein A-I Associated with the Activation of Lecithin:Cholesterol Acyltransferase*

D. Sviridov, N. Fidge, W. Sawyer, 2000, The Journal of Biological Chemistry.

Cholesterol transport between cells and high density lipoprotein subfractions from obese and lean subjects.

D. Sviridov, P. Nestel, N. Fidge, 1997, Journal of lipid research.

Inhibition of cholesterol synthesis and esterification regulates high density lipoprotein interaction with isolated epithelial cells of human small intestine.

D. Sviridov, M. Pavlov, V. Smirnov, 1990, Journal of lipid research.

Binding of partially reassembled high-density lipoprotein to isolated human small intestine epithelial cells. Effect of lipid composition.

D. Sviridov, V. Smirnov, V. Repin, 1988, Biochimica et biophysica acta.

Cholesterol regulates high-density lipoprotein interaction with isolated epithelial cells of human small intestine.

D. Sviridov, V. Smirnov, V. Repin, 1987, Biochimica et biophysica acta.

Effect of lovastatin on the interaction between high density lipoprotein and cultured rat adrenocortical cells.

D. Sviridov, N. Fidge, V. Repin, 1991, Atherosclerosis.

Effect of the inhibitors of different steps of cholesterol biosynthesis pathway on high density lipoprotein binding to isolated human enterocytes

D. Sviridov, M. Pavlov, V. Repin, 1993 .

Studies on the proteins involved in the interaction of high‐density lipoprotein with isolated human small intestine epithelial cells

D. Sviridov, C. Ehnholm, V. Repin, 1992, FEBS letters.

Specific high affinity binding and degradation of high density lipoproteins by isolated epithelial cells of human small intestine.

V. A. Gusev, D. Sviridov, V. Smirnov, 1986, Metabolism: clinical and experimental.

Cholesterol Efflux-Independent Modification of Lipid Rafts by AIBP (Apolipoprotein A-I Binding Protein)

H. Low, P. Meikle, M. Bukrinsky, 2020, Arteriosclerosis, thrombosis, and vascular biology.

Asymmetry in the Lipid Affinity of Bihelical Amphipathic Peptides

D. Sviridov, H. Brewer, A. Remaley, 2008, Journal of Biological Chemistry.

The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport.

D. Sviridov, D. Blum, N. Mukhamedova, 2008, Cardiovascular research.

Apolipoprotein A-I stimulates the transport of intracellular cholesterol to cell-surface cholesterol-rich domains (caveolae).

D. Sviridov, C. Fielding, N. Fidge, 2001, The Biochemical journal.

Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles.

D. Sviridov, N. Fidge, L. Pyle, 1996, Biochemistry.

Efflux of intracellular versus plasma membrane cholesterol in HepG2 cells: different availability and regulation by apolipoprotein A-I.

D. Sviridov, N. Fidge, 1995, Journal of lipid research.

Deletion of the propeptide of apolipoprotein A-I reduces protein expression but stimulates effective conversion of prebeta-high density lipoprotein to alpha-high density lipoprotein.

D. Sviridov, M. Jauhiainen, C. Ehnholm, 2000, Journal of lipid research.

ABCA12 regulates insulin secretion from β‐cells

P. Das, H. Low, P. Meikle, 2020, EMBO reports.

Time response of cholesterol synthesis inhibition by compactin-related compunds.In vitro quantitation of the “Escape Phenomenon”

D. Sviridov, M. Pavlov, A. Endo, 1993, Lipids.

Specific binding of3H-naloxone with isolated rat enterocytes

D. Sviridov, K. Yarygin, V. Repin, 1985, Bulletin of Experimental Biology and Medicine.

Downregulation of Cyp7a1 by Cholic Acid and Chenodeoxycholic Acid in Cyp27a1/ApoE Double Knockout Mice: Differential Cardiovascular Outcome

D. Sviridov, B. Vogt, G. Escher, 2020, Frontiers in Endocrinology.

Effect of Cyp27A1 gene dosage on atherosclerosis development in ApoE‐knockout mice

D. Sviridov, B. Vogt, F. Frey, 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Sterol 27-hydroxylase gene dosage and the antiatherosclerotic effect of Rifampicin in mice

D. Sviridov, B. Vogt, G. Escher, 2017, Bioscience reports.

Regulation of cholesterol uptake in the rat intestinal cell line.

D. Sviridov, P. Rampal, V. Repin, 1994, Biochimica et biophysica acta.

New model to study cholesterol uptake in the human intestine in vitro.

D. Sviridov, P. Rampal, M. Pavlov, 1993, Journal of lipid research.

Human Immunodeficiency Virus Impairs Reverse Cholesterol Transport from Macrophages

M. Bukrinsky, D. Sviridov, J. Orenstein, 2006, PLoS Biology.

Inhibition of cholesterol synthesis by lovastatin tested on six human cell typesin vitro

D. Sviridov, E. Podrez, M. Pavlov, 1990, Lipids.

Stimulation of the Liver X Receptor Pathway Inhibits HIV-1 Replication via Induction of ATP-Binding Cassette Transporter A1

F. Kashanchi, M. Bukrinsky, D. Sviridov, 2010, Molecular Pharmacology.

Regulation of cholesterol synthesis in isolated epithelial cells of human small intestine

D. Sviridov, V. Smirnov, V. Repin, 1986, Lipids.

Lipids, biomarkers, and subclinical atherosclerosis in treatment-naive HIV patients starting or not starting antiretroviral therapy: Comparison with a healthy control group in a 2-year prospective study

H. Low, D. Sviridov, D. Podzamczer, 2020, PloS one.

A Mouse Model of Harlequin Ichthyosis Delineates a Key Role for Abca12 in Lipid Homeostasis

P. Meikle, D. Sviridov, M. Bahlo, 2008, PLoS genetics.

Neutrophil Activation Is Attenuated by High-Density Lipoprotein and Apolipoprotein A-I in In Vitro and In Vivo Models of Inflammation

D. Sviridov, A. Murphy, J. Shaw, 2011, Arteriosclerosis, thrombosis, and vascular biology.

Comparison of the effect of six compactin-related compounds on cholesterol synthesis in five human cell types

D. Sviridov, M. Pavlov, A. Endo, 1990, Lipids.

Dose-Dependent Effect of Rosuvastatin on VLDL–Apolipoprotein C-III Kinetics in the Metabolic Syndrome

G. Watts, D. Sviridov, P. Nestel, 2008, Diabetes Care.

Structure/Function Relationships of Apolipoprotein A-I Mimetic Peptides: Implications for Antiatherogenic Activities of High-Density Lipoprotein

D. Sviridov, A. Murphy, A. Remaley, 2010, Circulation research.

A Model for Studying Platelet Interaction with Cellular and Macromolecular Constituents of the Vessel Wall In Vitro

D. Sviridov, V. Leytin, 1982 .

Cdc42 – A tryst between host cholesterol metabolism and infection

D. Sviridov, N. Mukhamedova, 2018, Small GTPases.

Extracellular vesicles carrying HIV-1 Nef induce trained immunity in myeloid cells

M. Bukrinsky, D. Sviridov, A. Murphy, 2022, bioRxiv.

Fenofibrate, homocysteine, cholesterol efflux and primum non nocere.

D. Sviridov, 2011, Atherosclerosis.

Delineation of the role of pre-beta 1-HDL in cholesterol efflux using isolated pre-beta 1-HDL.

D. Sviridov, P. Nestel, A. Hoang, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Efflux of Cellular Cholesterol and Phospholipid to Apolipoprotein A-I Mutants*

D. Sviridov, N. Fidge, L. Pyle, 1996, The Journal of Biological Chemistry.

Inhibition of Extracellular Cyclophilins with Cyclosporine Analog and Development of Atherosclerosis in Apolipoprotein E–Deficient Mice

M. Bukrinsky, D. Sviridov, G. Fischer, 2015, The Journal of Pharmacology and Experimental Therapeutics.

An Apolipoprotein A-I Mimetic Peptide Designed with a Reductionist Approach Stimulates Reverse Cholesterol Transport and Reduces Atherosclerosis in Mice

D. Sviridov, A. Remaley, J. D. de Haan, 2013, PloS one.

Inhibition of Neuroinflammation by AIBP: Spinal Effects upon Facilitated Pain States.

H. Low, D. Sviridov, Soo-Ho Choi, 2018, Cell reports.

Delineation of the Role of Pre-1-HDL in Cholesterol Efflux Using Isolated Pre-1-HDL

D. Sviridov, P. Nestel, A. Hoang, 2002 .

Pathway of cholesterol efflux from human hepatoma cells.

D. Sviridov, N. Fidge, 1995, Biochimica et biophysica acta.

Cytomegalovirus Restructures Lipid Rafts via a US28/CDC42-Mediated Pathway, Enhancing Cholesterol Efflux from Host Cells.

H. Low, P. Meikle, M. Bukrinsky, 2016, Cell reports.

Cholesterol efflux assay.

H. Low, D. Sviridov, A. Hoang, 2012, Journal of visualized experiments : JoVE.

High Density Lipoprotein Reduces Lipid Induced Macrophage Inflammation and Enhances Insulin Mediated Glucose Uptake in Human Skeletal Muscle

D. Sviridov, B. Kingwell, B. Drew, 2010 .

Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein.

D. Sviridov, J. Sasaki, N. Fidge, 2001, Atherosclerosis.

Effectivity of expression of mature forms of mutant human apolipoprotein A-I.

D. Sviridov, N. Fidge, L. Pyle, 1999, Protein expression and purification.

Dose-Dependent Effect of Rosuvastatin on Very-Low Density Lipoprotein-Apolipoprotein C-III Kinetics in the Metabolic Syndrome

G. Watts, D. Sviridov, P. Nestel, 2008 .

Expression of Sterol 27-Hydroxylase (CYP27A1) Enhances Cholesterol Efflux*

D. Sviridov, K. Croft, Z. Krozowski, 2003, The Journal of Biological Chemistry.

Apolipoprotein B-100 and apoA-II kinetics as determinants of cellular cholesterol efflux.

G. Watts, D. Sviridov, P. Nestel, 2012, The Journal of clinical endocrinology and metabolism.

Characterization of the maturation of human pro-apolipoprotein A-I in an in vitro model.

D. Sviridov, N. Fidge, L. Pyle, 2001, Biochemistry.

The role of different regions of ATP-binding cassette transporter A1 in cholesterol efflux.

M. Bukrinsky, D. Sviridov, A. Remaley, 2007, Biochemistry.

Lipid rafts as a therapeutic target

D. Sviridov, N. Mukhamedova, Yury I. Miller, 2020, Journal of Lipid Research.

Extracellular vesicles carrying HIV-1 Nef induce long-term hyperreactivity of myeloid cells

M. Bukrinsky, D. Sviridov, A. Murphy, 2022, Cell reports.

HIV and Cardiovascular Disease: Contribution of HIV-Infected Macrophages to Development of Atherosclerosis

M. Bukrinsky, D. Sviridov, 2007, PLoS medicine.

Demethylation using the epigenetic modifier, 5-azacytidine, increases the efficiency of transient transfection of macrophages Published, JLR Papers in Press, November 1, 2004. DOI 10.1194/jlr.D400014-JLR200

D. Sviridov, A. El-Osta, Z. Krozowski, 2005, Journal of Lipid Research.

Specific NLRP3 Inhibition Protects Against Diabetes-Associated Atherosclerosis

D. Sviridov, A. Murphy, J. D. de Haan, 2020, Diabetes.

Antiretroviral compounds and cholesterol efflux from macrophages.

M. Bukrinsky, D. Sviridov, A. Dart, 2009, Atherosclerosis.

Biology of Lipid Rafts: Introduction to the Thematic Review Series

D. Sviridov, Yury I. Miller, 2020, Journal of Lipid Research.

Small GTPase ARF6 Regulates Endocytic Pathway Leading to Degradation of ATP-Binding Cassette Transporter A1

M. Bukrinsky, D. Sviridov, N. Mukhamedova, 2016, Arteriosclerosis, thrombosis, and vascular biology.

Impact of freezing on high-density lipoprotein functionality.

D. Sviridov, A. Murphy, B. Kingwell, 2008, Analytical biochemistry.

Endothelial cell culture on fibrillar collagen: model to study platelet adhesion and liposome targeting to intercellular collagen matrix.

D. Sviridov, V. Torchilin, V. Koteliansky, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Endothelial cell cultures of fibrillar collagen: partial reconstitution of the vessel wall and platelet adhesion.

D. Sviridov, V. Smirnov, V. Repin, 1980, Thrombosis research.

The macrophage: the intersection between HIV infection and atherosclerosis

M. Bukrinsky, D. Sviridov, S. Crowe, 2010, Journal of leukocyte biology.

Lipid rafts and pathogens: the art of deception and exploitation

M. Bukrinsky, D. Sviridov, N. Mukhamedova, 2019, Journal of Lipid Research.

The lysosome: A potential juncture between SARS‐CoV‐2 infectivity and Niemann‐Pick disease type C, with therapeutic implications

M. Bukrinsky, D. Sviridov, A. Remaley, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Method of obtaining a long-living intestinal tissue culture

M. B. Kuberger, D. Sviridov, I. Safonova, 1989, Bulletin of Experimental Biology and Medicine.

Comorbidities of HIV infection: role of Nef-induced impairment of cholesterol metabolism and lipid raft functionality

A. Makarov, M. Bukrinsky, D. Sviridov, 2019, AIDS.

Comorbidities of HIV infection: role of Nef-induced impairment of cholesterol metabolism and lipid raft functionality

A. Makarov, M. Bukrinsky, D. Sviridov, 2019, AIDS.

ABCA12 regulates ABCA1-dependent cholesterol efflux from macrophages and the development of atherosclerosis.

K. J. Henley, D. Sviridov, B. Kile, 2013, Cell metabolism.

Reconstituted High-Density Lipoprotein Attenuates Platelet Function in Individuals With Type 2 Diabetes Mellitus by Promoting Cholesterol Efflux

D. Sviridov, M. Cooper, B. Kingwell, 2009, Circulation.

Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque

D. Sviridov, A. Murphy, A. Dart, 2008, Circulation research.

Trained Immunity and HIV Infection

M. Bukrinsky, D. Sviridov, Yury I. Miller, 2022, Frontiers in Immunology.

Native LDL promotes differentiation of human monocytes to macrophages with an inflammatory phenotype

K. Andrews, D. Sviridov, A. Murphy, 2015, Thrombosis and Haemostasis.

Both apolipoproteins B-48 and B-100 are synthesized and secreted by the human intestine.

M. B. Kuberger, D. Sviridov, J. Hoeg, 1990, Journal of lipid research.

Modification of lipid rafts by extracellular vesicles carrying HIV-1 protein Nef induces redistribution of amyloid precursor protein and Tau, causing neuronal dysfunction

H. Low, M. Bukrinsky, A. Hill, 2020, The Journal of Biological Chemistry.

Mutation of the ATP cassette binding transporter A1 (ABCA1) C-terminus disrupts HIV-1 Nef binding but does not block the Nef enhancement of ABCA1 protein degradation.

Angela Grant, M. Bukrinsky, D. Sviridov, 2010, Biochemistry.

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages

M. Bukrinsky, D. Sviridov, M. Morrow, 2006, Retrovirology.

Correction: A Mouse Model of Harlequin Ichthyosis Delineates a Key Role for Abca12 in Lipid Homeostasis

P. Meikle, D. Sviridov, M. Bahlo, 2008, PLoS Genetics.

Effects of High-Density Lipoprotein Elevation With Cholesteryl Ester Transfer Protein Inhibition on Insulin Secretion

D. Sviridov, B. Kingwell, J. Forbes, 2013, Circulation research.

Effects of HDL Elevation with CETP Inhibition on Insulin Secretion

D. Sviridov, B. Kingwell, J. Forbes, 2013 .

High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus

D. Sviridov, M. Febbraio, B. Kemp, 2009, Circulation.

Anti-Inflammatory Functions of Apolipoprotein A-I and High-Density Lipoprotein Are Preserved in Trimeric Apolipoprotein A-I

D. Sviridov, A. Murphy, J. Chin-Dusting, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties

D. Sviridov, A. Murphy, M. Cooper, 2007, Diabetologia.

Dynamics of reverse cholesterol transport: protection against atherosclerosis.

D. Sviridov, P. Nestel, 2002, Atherosclerosis.

Non-linear optical imaging of atherosclerotic plaques in the context of SIV and HIV infection prominently detects crystalline cholesterol esters

M. Bukrinsky, D. Sviridov, E. Latz, 2021, PloS one.

Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux.

M. Bukrinsky, D. Sviridov, K. Mansfield, 2010, The Journal of infectious diseases.

TRAK2, a novel regulator of ABCA1 expression, cholesterol efflux and HDL biogenesis

J. Blangero, H. Low, D. Sviridov, 2017, European heart journal.

Exosomes containing HIV protein Nef reorganize lipid rafts potentiating inflammatory response in bystander cells

H. Low, P. Meikle, M. Bukrinsky, 2019, PLoS pathogens.

An internal standard for protein purification by affinity sorption

D. Sviridov, N. Mukhamedova, Ying Fu, 2013 .

HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux[S]

M. Bukrinsky, D. Sviridov, K. Gaus, 2012, Journal of Lipid Research.

Prion Infection Impairs Cholesterol Metabolism in Neuronal Cells*

P. Meikle, M. Bukrinsky, A. Hill, 2013, The Journal of Biological Chemistry.

Short Communication: Accumulation of Neutral Lipids in Liver and Aorta of Nef-Transgenic Mice.

M. Bukrinsky, D. Sviridov, S. Nedospasov, 2016, AIDS research and human retroviruses.

Direct interaction between ABCA1 and HIV-1 Nef: Molecular modeling and virtual screening for inhibitors

A. Makarov, M. Bukrinsky, D. Sviridov, 2021, Computational and structural biotechnology journal.

Targeting Lipid Rafts—A Potential Therapy for COVID-19

M. Bukrinsky, D. Sviridov, A. Remaley, 2020, Frontiers in Immunology.

HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications

D. Sviridov, A. Remaley, M. Amar, 2008, Expert review of cardiovascular therapy.

HIV protein Nef causes dyslipidemia and formation of foam cells in mouse models of atherosclerosis

M. Bukrinsky, D. Sviridov, M. Geyer, 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

High-Density Lipoprotein Reduces the Human Monocyte Inflammatory Response

D. Sviridov, A. Murphy, A. Remaley, 2008, Arteriosclerosis, thrombosis, and vascular biology.

Lipids and the endothelium: an update

D. Sviridov, A. Murphy, J. Chin-Dusting, 2006 .

Lipids and the endothelium : an update – PERSPECTIVE

D. Sviridov, A. Murphy, J. Chin-Dusting, 2006 .

Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models

H. Low, D. Sviridov, P. Nestel, 2012, Diabetologia.

Global functional knockdown of ATP binding cassette transporter A1 stimulates development of atherosclerosis in apoE K/O mice.

H. Low, D. Sviridov, G. Chimini, 2011, Biochemical and biophysical research communications.

Maturation of apolipoprotein A-I: unrecognized health benefit or a forgotten rudiment?11 See referenced article, J. Lipid Res. 2009, 50: 1330–1339.

D. Sviridov, 2009, Journal of Lipid Research.

The anti inflammatory effects of high density lipoproteins.

D. Sviridov, A. Murphy, J. Chin-Dusting, 2009, Current medicinal chemistry.

Innate immune receptor NOD2 promotes vascular inflammation and formation of lipid‐rich necrotic cores in hypercholesterolemic mice

J. Borén, H. Low, D. Sviridov, 2014, European journal of immunology.

Fetal inhibition of inflammation improves disease phenotypes in harlequin ichthyosis.

K. J. Henley, P. Meikle, D. Sviridov, 2015, Human molecular genetics.

Many ABCs make light work with cholesterol

D. Sviridov, 2013, Aging.

Elevated HDL Cholesterol is Functionally Ineffective in Cardiac Transplant Recipients: Evidence for Impaired Reverse Cholesterol Transport

D. Sviridov, A. Dart, B. Kingwell, 2006, Transplantation.

Caveolin-1 Plays a Critical Role in the Differentiation of Monocytes into Macrophages

P. Meikle, D. Sviridov, M. Parat, 2012, Arteriosclerosis, thrombosis, and vascular biology.

HIV-1 Protein Nef Inhibits Activity of ATP-binding Cassette Transporter A1 by Targeting Endoplasmic Reticulum Chaperone Calnexin*

Anastas Popratiloff, M. Bukrinsky, D. Sviridov, 2014, The Journal of Biological Chemistry.

Antiatherogenic functionality of high density lipoprotein: how much versus how good.

D. Sviridov, A. Remaley, P. Nestel, 2008, Journal of atherosclerosis and thrombosis.

Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein.

H. Low, D. Sviridov, A. Remaley, 2012, European heart journal.

Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus.

E. Tai, D. Sviridov, E. Chan, 2011, Journal of clinical lipidology.

High-density lipoprotein mimetics: promises and challenges.

D. Sviridov, A. Remaley, 2015, The Biochemical journal.

HIV infection induces structural and functional changes in high density lipoproteins.

M. Bukrinsky, D. Sviridov, R. Welti, 2015, Atherosclerosis.

Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism in individuals with prediabetes: A randomized controlled trial.

C. Cobelli, P. Meikle, D. Sviridov, 2016, Metabolism: clinical and experimental.

The ATP binding cassette transporter, ABCG1, localizes to cortical actin filaments

D. Sviridov, R. Whan, K. Gaus, 2017, Scientific Reports.

High-Density Lipoprotein – A Hero, a Mirage, or a Witness?

D. Sviridov, 2014, Front. Cardiovasc. Med..

Structure-function studies of apoA-I variants: site-directed mutagenesis and natural mutations.

D. Sviridov, Wei Huang, J. Sasaki, 2002, Journal of lipid research.

Natural mutations of apolipoprotein A-I impairing activation of lecithin:cholesterol acyltransferase.

D. Sviridov, Wei Huang, J. Sasaki, 2003, Biochimica et biophysica acta.

5A Apolipoprotein Mimetic Peptide Promotes Cholesterol Efflux and Reduces Atherosclerosis in Mice

D. Sviridov, A. Remaley, M. Amar, 2010, Journal of Pharmacology and Experimental Therapeutics.

Apolipoprotein A-I Mimetic Peptides: Discordance Between In Vitro and In Vivo Properties—Brief Report

D. Sviridov, A. Remaley, J. Chin-Dusting, 2017, Arteriosclerosis, thrombosis, and vascular biology.

Associations between surface markers on blood monocytes and carotid atherosclerosis in HIV‐positive individuals

D. Sviridov, S. Lewin, A. Dart, 2014, Immunology and cell biology.

The effect of HIV infection on atherosclerosis and lipoprotein metabolism: a one year prospective study.

H. Low, M. Bukrinsky, D. Sviridov, 2013, Atherosclerosis.

HIV infection and high density lipoprotein metabolism.

M. Bukrinsky, D. Sviridov, A. Dart, 2008, Atherosclerosis.

Abundance of Nef and p-Tau217 in Brains of Individuals Diagnosed with HIV-Associated Neurocognitive Disorders Correlate with Disease Severance

S. Nekhai, M. Bukrinsky, D. Sviridov, 2021, Molecular Neurobiology.

Cholesterol transport between red blood cells and lipoproteins contributes to cholesterol metabolism in blood.

H. Low, P. Meikle, D. Sviridov, 2020, Journal of lipid research.

Cholesterol transport between red blood cells and lipoproteins contributes to cholesterol metabolism in blood.

H. Low, P. Meikle, D. Sviridov, 2020, Journal of lipid research.

Antibodies against high-density lipoprotein binding proteins enhance high-density lipoprotein uptake but do not affect cholesterol efflux from rat hepatoma cells.

D. Sviridov, P. Nestel, N. Fidge, 1997, The international journal of biochemistry & cell biology.

HIV disease, metabolic dysfunction and atherosclerosis: A three year prospective study

H. Low, Lesley Cheng, Maria-Silvana Di Yacovo, 2019, PloS one.

Ins and outs of the ATP-binding cassette transporter A1.

D. Sviridov, Yury I. Miller, 2016, Current opinion in lipidology.

Production of mature human apolipoprotein A-I in a baculovirus-insect cell system: propeptide is not essential for intracellular processing but may assist rapid secretion.

D. Sviridov, P. Barton, N. Fidge, 1997, Analytical biochemistry.

Cholesterol uptake in the human intestine. Hypo- and hyperresponsiveness.

D. Sviridov, P. Rampal, V. Repin, 1993, Biochimica et biophysica acta.

Cholesterol: a dark horse in signalling race.

D. Sviridov, N. Mukhamedova, 2017, Current opinion in lipidology.

Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.

D. Sviridov, A. Murphy, B. Kingwell, 2009, Journal of the American College of Cardiology.

High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus

D. Sviridov, M. Febbraio, B. Kemp, 2009, Circulation.

A gel-based method for purification of apolipoprotein A-I from small volumes of plasma

D. Sviridov, S. McCormick, Brie Sorrenson, 2010, Journal of Lipid Research.

Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism in individuals with prediabetes: A randomized controlled trial.

C. Cobelli, P. Meikle, D. Sviridov, 2016, Metabolism: clinical and experimental.

Abstract 5869: HDL and ApoA-I Attenuate Neutrophil Activation in in vitro and in vivo Models of Inflammation: A Role for Lipid Rafts

D. Sviridov, A. Murphy, J. Shaw, 2009 .

High‐density lipoprotein inhibits human M1 macrophage polarization through redistribution of caveolin‐1

D. Sviridov, A. Murphy, Yi Fu, 2016, British journal of pharmacology.

HIV protein Nef causes dyslipidemia and formation of foam cells in mouse models of atherosclerosis

M. Bukrinsky, D. Sviridov, M. Geyer, 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Effect of Cyp27A1 gene dosage on atherosclerosis development in ApoE‐knockout mice

D. Sviridov, B. Vogt, F. Frey, 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

D. Sviridov, A. El-Osta, Z. Krozowski, 2005, Journal of Lipid Research.

Time-response changes in the thrombogenicity of platelets spread on a collagen-coated surface.

D. Sviridov, V. Smirnov, V. Repin, 1980, Thrombosis research.

Not a day without microRNA.

A. Hill, D. Sviridov, 2015, Current opinion in lipidology.

Introduction

D. Sviridov, 2010, Clinical and experimental pharmacology & physiology.